Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 4,240,000 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,240,000 | 4,240,000 | - | - | Stock Option | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 3,755,760 | 3,755,760 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 3,755,760 | 0 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Emily Wang Fairbairn | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 3,038,743 | 3,038,743 | - | - | Pre-Funded Warrants (right to buy) | |
| IN8bio Inc | Emily Wang Fairbairn | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 3,038,743 | 3,038,743 | - | - | Series C Warrants (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,452,425 | 1,452,425 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,452,425 | 0 | - | - | Employee Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 1,307,408 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 1,307,408 | 1,307,408 | - | - | Stock Option | |
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 1,261,070 | 1,261,070 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 1,261,070 | 0 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,202,458 | 1,202,458 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,202,458 | 0 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 1,147,261 | 1,147,261 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 1,147,261 | 0 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,076,555 | 1,076,555 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,076,555 | 0 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,000,000 | 1,000,000 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 1,000,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 878,375 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 878,375 | 878,375 | - | - | Employee Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 840,000 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 840,000 | 840,000 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 709,952 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Srinivas G. Rao | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 709,952 | 709,952 | - | - | Stock Option | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 650,000 | 650,000 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 650,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| ATAI Life Sciences N.V. | Christian Angermayer | Director, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 624,000 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Christian Angermayer | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 624,000 | 624,000 | - | - | Stock Option | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 584,265 | 584,265 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 584,265 | 0 | - | - | Employee Stock Option (right to buy) | |
| ACM Research Inc (Class A) | Xiao Xing | Director | 04 Oct 2024 | 580,873 | 2,823,033 (17%) | 3% | 21.3 | 12,390,021 | Class A Common Stock | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 566,460 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 566,460 | 566,460 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 542,232 | 542,232 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 532,653 | 532,653 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 532,653 | 0 | - | - | Employee Stock Option (right to buy) | |
| X4 Pharma Inc | Paula S. Ragan | Director, President and CEO | 04 Oct 2024 | 532,081 | 1,297,149 (8%) | 3% | 0 | Common Stock | ||
| Skillsoft Corp (Class A) | Ronald W. Hovsepian | Director, CEO & Executive Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 500,000 | 500,000 | - | - | Restricted Stock Units | |
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 460,829 | 0 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 460,829 | 460,829 | - | - | Employee Stock Option (right to buy) | ||
| FrontView REIT Inc | Stephen Preston | Director, Chairman, Co-CEO and Co-Pres | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 427,818 | 427,818 | - | - | OP Units | |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 400,688 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 400,688 | 400,688 | - | - | Stock Option | |
| Cg Oncology Inc | Arthur Kuan | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 397,800 | 397,800 | - | - | Stock Option (Right to Buy) | |
| Algorhythm Holdings Inc | Milton C. Ault | Former 10% Owner | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 04 Oct 2024 | 365,100 | 945,000 (2%) | 0% | 0.7 | 267,253 | Common Stock |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 338,112 | 338,112 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Florian Brand | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 338,112 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 326,416 | 326,416 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Anne Nagengast Johnson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 326,416 | 0 | - | - | Stock Option | |
| FrontView REIT Inc | Stephen Preston | Director, Chairman, Co-CEO and Co-Pres | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 263,158 | 263,158 | - | - | Restricted Stock Units | |
| IN8bio Inc | Peter C. Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 253,164 | 517,604 | - | - | Common Stock | |
| IN8bio Inc | Peter C. Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 253,164 | 253,164 | - | - | Series C Warrants (right to buy) | |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Oct 2024 | 250,000 | 48,473,144 | - | - | Class B Common Stock | ||
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.88 per share. | 04 Oct 2024 | 250,000 | 0 | - | 22.9 | 5,720,375 | Class A Common Stock |
| Robinhood Markets Inc (Class A) | Vladimir Tenev | Director, Chief Executive Officer | 04 Oct 2024 | 250,000 | 250,000 | - | - | Class A Common Stock | ||
| X4 Pharma Inc | Paula S. Ragan | Director, President and CEO | 04 Oct 2024 | 239,436 | 1,057,713 (6%) | 1% | 0.5 | 131,522 | Common Stock | |
| X4 Pharma Inc | Adam S. Mostafa | Chief Financial Officer | 04 Oct 2024 | 230,645 | 230,645 (1%) | 1% | 0 | Common Stock | ||
| X4 Pharma Inc | Adam S. Mostafa | Chief Financial Officer | 04 Oct 2024 | 230,645 | 0 (0%) | 1% | 0.6 | 126,901 | Common Stock | |
| X4 Pharma Inc | Arthur Taveras | Chief Scientific Officer | 04 Oct 2024 | 230,645 | 464,946 (2%) | 1% | 0 | Common Stock | ||
| X4 Pharma Inc | Mary DiBiase | Chief Operating Officer | 04 Oct 2024 | 230,645 | 519,755 (3%) | 1% | 0 | Common Stock | ||
| Palantir | Ryan Taylor | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.72 per share. | 04 Oct 2024 | 195,500 | 526,869 | - | 4.7 | 922,760 | Class A Common Stock |
| Palantir | Ryan Taylor | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 195,500 | 590,004 | - | - | Employee Stock Option (Right to buy) | |
| Palantir | Ryan Taylor | See Remarks | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 04 Oct 2024 | 195,500 | 331,369 | - | 40.0 | 7,820,704 | Class A Common Stock |
| FrontView REIT Inc | Randall Starr | Director, Co-CEO and Co-President | 04 Oct 2024 | 178,258 | 178,258 | - | - | OP Units | ||
| Cg Oncology Inc | Ambaw Bellete | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 175,500 | 175,500 | - | - | Stock Option (Right to Buy) | |
| ACM Research Inc (Class A) | Xiao Xing | Director | 04 Oct 2024 | 173,005 | 2,530,901 (15%) | 1% | 23.3 | 4,034,477 | Class A Common Stock | |
| FrontView REIT Inc | Randall Starr | Director, Co-CEO and Co-President | 04 Oct 2024 | 171,053 | 171,053 | - | - | Restricted Stock Units | ||
| MoonLake Immunotherapeutics (Class A) | Simon John Sturge | Director | Sale of securities on an exchange or to another person at price $ 53.72 per share. | 04 Oct 2024 | 171,000 | 171,980 | - | 53.7 | 9,186,120 | Class A ordinary shares, par value $0.0001 per share |
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 143,540 | 0 | - | - | Employee Stock Option (right to buy) | ||
| ADT Inc | Donald M. Young | EVP & COO | 04 Oct 2024 | 143,540 | 143,540 | - | - | Employee Stock Option (right to buy) | ||
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 113.10 per share. | 04 Oct 2024 | 142,264 | 287,979 (0%) | 0% | 113.1 | 16,090,058 | Class A Common Stock |
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 140,662 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 140,662 | 140,662 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 140,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 140,000 | 140,000 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Dylan Hartley | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 137,603 | 137,603 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 135,100 | 135,100 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 135,100 | 0 | - | - | Employee Stock Option (right to buy) | |
| Cg Oncology Inc | Vijay Kasturi | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 132,600 | 132,600 | - | - | Stock Option (Right to Buy) | |
| OnKure Therapeutics Inc (Class A) | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 131,396 | 131,396 | - | - | Employee Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 130,611 | 130,611 | - | - | Employee Stock Option (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 126,582 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 285,030 | - | - | Common Stock | |
| IN8bio Inc | William Ho | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 2,548,094 | - | - | Common Stock | |
| IN8bio Inc | William Ho | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 126,582 | 126,582 | - | - | Series C Warrants (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 124,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 124,000 | 124,000 | - | - | Employee Stock Option (right to buy) | |
| ACM Research Inc (Class A) | Xiao Xing | Director | 04 Oct 2024 | 119,127 | 2,703,906 (16%) | 0% | 21.8 | 2,595,777 | Class A Common Stock | |
| ATAI Life Sciences N.V. | Anne Nagengast Johnson | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 115,152 | 0 | - | - | Stock Option | |
| ATAI Life Sciences N.V. | Anne Nagengast Johnson | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 115,152 | 115,152 | - | - | Stock Option | |
| IN8bio Inc | Alan S. Roemer | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 102,459 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Alan S. Roemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 102,459 | 102,459 | - | - | Series A Warrants (right to buy) | |
| ACM Research Inc (Class A) | Xiao Xing | Director | 04 Oct 2024 | 101,018 | 2,429,883 (14%) | 0% | 25.3 | 2,560,806 | Class A Common Stock | |
| Quantum Computing Inc | Robert B. Fagenson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 650,000 | - | - | Options to purchase Common Stock | |
| Quantum Computing Inc | Carl Scott Weimer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 200,000 | - | - | Options to purchase Common Stock | |
| Levi Strauss & Co. - Ordinary Shares Cls A | David A. Friedman | Director | 04 Oct 2024 | 100,000 | 116,676 (0%) | 0% | 0 | Class A Common Stock | ||
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 4,115,305 | - | - | Common Stock | |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 300,000 | - | - | Restricted Stock Unit | |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 97,324 | 97,324 | - | - | Restricted Stock Units | |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 111.75 per share. | 04 Oct 2024 | 95,032 | 192,947 (0%) | 0% | 111.8 | 10,619,826 | Class A Common Stock |
| Cg Oncology Inc | Corleen M. Roche | CFO | 04 Oct 2024 | 93,600 | 93,600 | - | - | Stock Option (Right to Buy) | ||
| ACM Research Inc (Class A) | Xiao Xing | Director | 04 Oct 2024 | 90,396 | 2,338,510 (14%) | 0% | 21.1 | 1,910,067 | Class A Common Stock | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 87,000 | 87,000 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | Omid Farokhzad | Director, CEO and Chair | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 87,000 | 0 | - | - | Employee Stock Option (right to buy) | |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 112.66 per share. | 04 Oct 2024 | 83,843 | 109,104 (0%) | 0% | 112.7 | 9,445,752 | Class A Common Stock |
| IN8bio Inc | Peter C. Brandt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 81,967 | 81,967 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Peter C. Brandt | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 81,967 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | William Ho | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 81,967 | 81,967 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | William Ho | Director, PRESIDENT AND CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 81,967 | 0 | - | - | Series A Warrants (right to buy) | |
| X4 Pharma Inc | Arthur Taveras | Chief Scientific Officer | 04 Oct 2024 | 76,920 | 388,026 (2%) | 0% | 0.6 | 43,306 | Common Stock | |
| Affiliated Managers Grp Inc | Thomas M. Wojcik | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 74.49 per share. | 04 Oct 2024 | 75,000 | 159,392 (0%) | 0% | 74.5 | 5,586,750 | Common Stock |
| Affiliated Managers Grp Inc | Thomas M. Wojcik | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 75,000 | 170,645 | - | - | Employee Stock Option (Right to Buy) | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 69,293 | 69,293 | - | - | Performance Share Units | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 04 Oct 2024 | 68,558 | 18,042 | - | - | Employee Stock Option (right to buy) | ||
| NuScale Power Corp (Class A) | Robert Temple | Retired | 04 Oct 2024 | 68,558 | 14,054 | - | 13.0 | 892,625 | Class A Common Stock | |
| NuScale Power Corp (Class A) | Robert Temple | Retired | 04 Oct 2024 | 68,558 | 82,612 | - | 6.4 | 439,457 | Class A Common Stock | |
| X4 Pharma Inc | Mary DiBiase | Chief Operating Officer | 04 Oct 2024 | 67,695 | 452,060 (2%) | 0% | 0.6 | 38,329 | Common Stock | |
| Anterix Inc | Ryan Gerbrandt | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 61,462 | 61,462 | - | - | Stock Option (Right to Buy) | |
| TTEC Holdings Inc | Kenneth R. Wagers | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 60,137 | 60,137 | - | - | Restricted Stock Units | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.50 per share. | 04 Oct 2024 | 60,000 | 219,009 (0%) | 0% | 64.5 | 3,870,198 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 60,000 | 732,079 | - | - | Stock Option (right to buy) | |
| Apple | Luca Maestri | Senior Vice President, CFO | Sale of securities on an exchange or to another person at price $ 226.52 per share. | 04 Oct 2024 | 59,305 | 107,788 (0%) | 0% | 226.5 | 13,433,769 | Common Stock |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 112.62 per share. | 04 Oct 2024 | 57,736 | 430,243 (1%) | 0% | 112.6 | 6,502,228 | Class A Common Stock |
| Affiliated Managers Grp Inc | Thomas M. Wojcik | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 181.18 per share. | 04 Oct 2024 | 53,599 | 105,793 (0%) | 0% | 181.2 | 9,711,067 | Common Stock |
| FrontView REIT Inc | Timothy D. Dieffenbacher | Chief Financial Officer | 04 Oct 2024 | 52,632 | 52,632 | - | - | Restricted Stock Units | ||
| FrontView REIT Inc | Drew Ireland | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 52,632 | 52,632 | - | - | Restricted Stock Units | |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 51.25 per share. | 04 Oct 2024 | 52,291 | 400,000 (0%) | 0% | 51.3 | 2,679,914 | Class A Common Stock |
| Cytosorbents Corp | Vincent J. Capponi | President and COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Cytosorbents Corp | Efthymios Nikolaos Deliargyris | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Pure Storage Inc (Class A) | John Colgrove | Director, Chief Visionary Officer | Sale of securities on an exchange or to another person at price $ 50.74 per share. | 04 Oct 2024 | 47,709 | 452,291 (0%) | 0% | 50.7 | 2,420,755 | Class A Common Stock |
| Algorhythm Holdings Inc | Milton C. Ault | Former 10% Owner | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 04 Oct 2024 | 46,900 | 1,310,000 (3%) | 0% | 0.5 | 22,174 | Common Stock |
| TTEC Holdings Inc | David J. Seybold | CEO, TTEC DIGITAL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 42,955 | 42,955 | - | - | Restricted Stock Units | |
| TTEC Holdings Inc | Margaret B. McLean | GC & CRO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 41,237 | 41,237 | - | - | Restricted Stock Units | |
| Travere Therapeutics Inc | Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.48 per share. | 04 Oct 2024 | 40,000 | 91,000 (0%) | 0% | 10.5 | 419,200 | Common Stock |
| Travere Therapeutics Inc | Gary A. Lyons | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 40,000 | 0 | - | - | Stock option (right to buy) | |
| Applied Digital Corp | Wesley Cummins | Director, CEO; Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.45 per share. | 04 Oct 2024 | 39,350 | 4,075,955 | - | 7.5 | 293,158 | Common Stock |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 37,691 | 37,691 | - | - | Warrants | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 36,950 | 473,536 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 36,497 | 36,497 | - | - | Restricted Stock Units | |
| Applied Digital Corp | David Rench | Chief Financial Officer | 04 Oct 2024 | 35,000 | 346,965 | - | - | Common Stock | ||
| Applied Digital Corp | David Rench | Chief Financial Officer | 04 Oct 2024 | 35,000 | 105,000 | - | - | Restricted Stock Unit | ||
| Seer Inc (Class A) | David R. Horn | President & CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 34,125 | 0 | - | - | Employee Stock Option (right to buy) | |
| Seer Inc (Class A) | David R. Horn | President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 34,125 | 34,125 | - | - | Employee Stock Option (right to buy) | |
| Clorox | Linda J. Rendle | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 32,639 | 136,278 (0%) | 0% | 161.6 | 5,273,483 | Common Stock |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 31,772 | 1,567,623 (0%) | 0% | 0 | Common Stock | |
| Skillsoft Corp (Class A) | Ronald W. Hovsepian | Director, CEO & Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 31,250 | 468,750 | - | - | Restricted Stock Units | |
| Skillsoft Corp (Class A) | Ronald W. Hovsepian | Director, CEO & Executive Chair | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 31,250 | 31,250 | - | 0 | Class A Common Stock | |
| Anterix Inc | Timothy A. Gray | Chief Financial Officer | 04 Oct 2024 | 30,731 | 30,731 | - | - | Stock Option (Right to Buy) | ||
| Anterix Inc | Gena L. Ashe | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 30,731 | 30,731 | - | - | Stock Option (Right to Buy) | |
| Southern Co | James Y. Kerr | Chairman, President & CEO, GAS | Sale of securities on an exchange or to another person at price $ 89.64 per share. | 04 Oct 2024 | 30,000 | 145,088 (0%) | 0% | 89.6 | 2,689,200 | Southern Company Common Stock |
| Rumble Inc (Class A) | Robert Arsov | Director | 04 Oct 2024 | 27,500 | 12,632,337 | - | 5.3 | 146,025 | Class A Common Stock, par value $0.0001 per share | |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 26,764 | 26,764 | - | - | Restricted Stock Units | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,985 | 25,985 | - | - | Performance Share Units | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 25,316 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 52,071 | - | - | Common Stock | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 25,316 | - | - | Series C Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 25,316 | 42,874 | - | - | Common Stock | |
| Tetra Technologies Inc | Timothy C. Moeller | SVP - Supply Chain & Chemicals | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 25,000 | 50,000 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Timothy C. Moeller | SVP - Supply Chain & Chemicals | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 25,000 | 339,066 (0%) | 0% | 0 | Common Stock | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 24,104 | 483,100 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 23,827 | 0 | - | 0 | Common Stock | |
| AMC Networks Inc (Class A) | Marianne Dolan Weber | Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 22,658 | 48,601 (0%) | 0% | - | Class A Common Stock | |
| AMC Networks Inc (Class A) | Marianne Dolan Weber | Member of 13(d) Group | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 22,658 | 0 | - | - | Restricted Stock Units | |
| Weave Comm Inc | Alan Taylor | Chief Financial Officer | 04 Oct 2024 | 22,356 | 424,485 | - | 13 | 290,628 | Common Stock | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 21,898 | 21,898 | - | - | Restricted Stock Units | |
| American Battery Tech Co | Andres Manuel Meza | Former Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 21,875 | 192,803 (0%) | 0% | 0 | Common Stock | |
| Travere Therapeutics Inc | Gary A. Lyons | Director | Sale of securities on an exchange or to another person at price $ 14.35 per share. | 04 Oct 2024 | 21,179 | 69,821 (0%) | 0% | 14.3 | 303,874 | Common Stock |
| Trade Desk Inc (Class A) | Jeffrey Terry Green | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 113.35 per share. | 04 Oct 2024 | 21,125 | 87,979 (0%) | 0% | 113.4 | 2,394,519 | Class A Common Stock |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 20,492 | 20,492 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Patrick McCall | CHIEF FINANCIAL OFFICER | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 20,492 | 0 | - | - | Series A Warrants (right to buy) | |
| SKYX Platforms Corp | Steven M. Schmidt | President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 20,000 | 20,000 | - | - | Series A-1 Preferred Stock | |
| Ares Management Corp (Class A) | Ryan Berry | Chief Mktg. & Strategy Officer | 04 Oct 2024 | 20,000 | 344,202 (0%) | 0% | 160.1 | 3,201,400 | Class A Common Stock | |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 19,056 | 19,056 | - | - | Performance Share Units | |
| Hallador Energy Co | Charles Wesley | Director | Other type of transaction at price $ 6.89 per share. | 04 Oct 2024 | 19,050 | 203,352 (0%) | 0% | 6.9 | 131,255 | Common Stock |
| Travere Therapeutics Inc | Gary A. Lyons | Director | Sale of securities on an exchange or to another person at price $ 15.15 per share. | 04 Oct 2024 | 18,821 | 51,000 (0%) | 0% | 15.2 | 285,227 | Common Stock |
| DocGo Inc | Lee Bienstock | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 04 Oct 2024 | 18,598 | 1,136,906 | - | 3.3 | 62,303 | Common Stock |
| OnKure Therapeutics Inc (Class A) | Samuel Agresta | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 18,588 | 18,588 | - | - | Employee Stock Option (right to buy) | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 18,174 | 279,729 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 17,979 | 491,594 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 17,979 | 17,980 | - | - | Restricted Stock Units | |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 16,898 | 16,898 | - | - | Employee Stock Option (right to buy) | |
| ACM Research Inc (Class A) | Mark McKechnie | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.60 per share. | 04 Oct 2024 | 16,516 | 17,416 (0%) | 0% | 5.6 | 92,490 | Class A Common Stock |
| ACM Research Inc (Class A) | Mark McKechnie | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 16,516 | 45,000 | - | - | Stock Option | |
| ACM Research Inc (Class A) | Mark McKechnie | See Remarks | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 04 Oct 2024 | 16,516 | 900 (0%) | 0% | 22 | 363,352 | Class A Common Stock |
| Prairie Operating Co | Kessler Paul | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 16,400 | 1,504,113 (2%) | 0% | 0 | Common Stock | |
| OnKure Therapeutics Inc (Class A) | Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 16,331 | 16,331 | - | - | Class A Common Stock | |
| Datadog Inc (Class A) | Shardul Shah | Director | Sale of securities on an exchange or to another person at price $ 120.02 per share. | 04 Oct 2024 | 15,832 | 459,449 (0%) | 0% | 120.0 | 1,900,185 | Class A Common Stock |
| Cg Oncology Inc | Leonard E. Post | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Cg Oncology Inc | Susan E. Graf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Cg Oncology Inc | Hong Fang Song | Director | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | ||
| Cg Oncology Inc | Brian Liu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| Cg Oncology Inc | Victor Tong | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,600 | 15,600 | - | - | Stock Option (Right to Buy) | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,591 | 15,591 | - | - | Performance Share Units | |
| OnKure Therapeutics Inc (Class A) | Edward T. Mathers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | R. Michael Carruthers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Isaac Manke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Andrew Phillips | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| OnKure Therapeutics Inc (Class A) | Valerie Malyvanh Jansen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 15,300 | 15,300 | - | - | Stock Option (right to buy) | |
| United Natural Foods Inc | Danielle Benedict | Chief Human Resources Officer | Sale of securities on an exchange or to another person at price $ 19.78 per share. | 04 Oct 2024 | 15,152 | 100,423 (0%) | 0% | 19.8 | 299,707 | Common Stock |
| FrontView REIT Inc | Ernesto Perez | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 14,802 | 14,802 | - | - | OP Units(1) | |
| Paychex | Michael E. Gioja | Sr. Vice President | 04 Oct 2024 | 14,731 | 29,246 (0%) | 0% | 57.2 | 843,202 | Common Stock | |
| Paychex | Michael E. Gioja | Sr. Vice President | 04 Oct 2024 | 14,731 | 26,428 | - | - | Stock Option | ||
| Paychex | Michael E. Gioja | Sr. Vice President | 04 Oct 2024 | 14,731 | 14,515 (0%) | 0% | 139.2 | 2,050,261 | Common Stock | |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 14,540 | 458,996 (0%) | 0% | 40.4 | 587,852 | Common Stock $.01 Par Value ND |
| Skillsoft Corp (Class A) | Ronald W. Hovsepian | Director, CEO & Executive Chair | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.75 per share. | 04 Oct 2024 | 13,859 | 17,391 | - | 15.7 | 218,279 | Class A Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 04 Oct 2024 | 13,351 | 1,602,231 (5%) | 0% | 1.3 | 16,689 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 13,351 | 101,790 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 4.96 per share. | 04 Oct 2024 | 13,351 | 1,588,880 (5%) | 0% | 5.0 | 66,204 | Common Stock |
| Concentrix Corp | Christopher A. Caldwell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 12,928 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Concentrix Corp | Christopher A. Caldwell | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.39 per share. | 04 Oct 2024 | 12,928 | 251,664 | - | 31.4 | 405,810 | Common Stock |
| Build A Bear Workshop Inc | Voin Todorovic | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.42 per share. | 04 Oct 2024 | 12,635 | 90,695 (0%) | 0% | 35.4 | 447,576 | Common Stock |
| American Battery Tech Co | Andres Manuel Meza | Former Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 12,576 | 12,576 | - | - | Warrants | |
| Applied Digital Corp | Michael Maniscalco | Chief Technology Officer | 04 Oct 2024 | 12,500 | 37,500 | - | - | Restricted Stock Unit | ||
| Applied Digital Corp | Michael Maniscalco | Chief Technology Officer | 04 Oct 2024 | 12,500 | 130,903 | - | - | Common Stock | ||
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 341.23 per share. | 04 Oct 2024 | 12,390 | 169,853 (0%) | 0% | 341.2 | 4,227,889 | Common Stock |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 04 Oct 2024 | 12,295 | 0 | - | - | Series A Warrants (right to buy) | |
| IN8bio Inc | Kate Rochlin | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 12,295 | 12,295 | - | - | Series A Warrants (right to buy) | |
| Enliven Therapeutics Inc | Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 12,206 | 1,036,523 | - | 27.5 | 335,792 | Common Stock |
| Clorox | Eric H. Reynolds | EVP - Chief Operating Officer | 04 Oct 2024 | 12,205 | 55,959 (0%) | 0% | 161.6 | 1,971,962 | Common Stock | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 11,856 | 284,433 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Fluor Corp | Joseph L. Brennan | EVP, CHIEF FINANCIAL OFFICER | 04 Oct 2024 | 11,619 | 41,908 (0%) | 0% | 50.3 | 584,401 | Common Stock | |
| NewtekOne Inc | Barry Sloane | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 11,532 | 1,158,855 (5%) | 0% | 0 | Common stock | |
| Applied Digital Corp | David Rench | Chief Financial Officer | 04 Oct 2024 | 11,385 | 335,580 | - | 7.4 | 84,818 | Common Stock | |
| NewtekOne Inc | Michael A. Schwartz | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 11,326 | 60,655 (0%) | 0% | 0 | Common stock | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 342.27 per share. | 04 Oct 2024 | 10,644 | 159,209 (0%) | 0% | 342.3 | 3,643,133 | Common Stock |
| Clorox | Kevin B. Jacobsen | EVP - Chief Financial Officer | 04 Oct 2024 | 10,613 | 51,399 (0%) | 0% | 161.6 | 1,714,742 | Common Stock | |
| NewtekOne Inc | Peter Mathison Downs | Director, Chief Lending Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 10,297 | 91,379 (0%) | 0% | 0 | Common stock | |
| Enliven Therapeutics Inc | Benjamin Hohl | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 10,218 | 0 | - | 27.5 | 281,079 | Common Stock |
| Enliven Therapeutics Inc | Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 10,218 | 182,140 | - | - | Stock Option (right to buy) | |
| Enliven Therapeutics Inc | Benjamin Hohl | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share. | 04 Oct 2024 | 10,218 | 10,218 | - | 2.5 | 25,341 | Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Amanda Whalen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.36 per share. | 04 Oct 2024 | 10,000 | 422,813 | - | 35.4 | 353,600 | Series A Common Stock |
| Klaviyo Inc - Ordinary Shares - Series A | Amanda Whalen | Chief Financial Officer | 04 Oct 2024 | 10,000 | 432,813 | - | - | Series A Common Stock | ||
| Klaviyo Inc - Ordinary Shares - Series A | Amanda Whalen | Chief Financial Officer | 04 Oct 2024 | 10,000 | 605,118 | - | - | Series B Common Stock | ||
| SKYX Platforms Corp | Leonard J. Sokolow | Director, Co-Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 10,000 | 10,000 | - | - | Series A-1 Preferred Stock | |
| SKYX Platforms Corp | John P. Campi | Co-Chief Executive Officer | 04 Oct 2024 | 10,000 | 10,000 | - | - | Series A-1 Preferred Stock | ||
| Expedia Group | Dara Khosrowshahi | Director | Sale of securities on an exchange or to another person at price $ 150.18 per share. | 04 Oct 2024 | 10,000 | 198,505 (0%) | 0% | 150.2 | 1,501,788 | Common Stock |
| Frontier Grp Holdings Inc | Steve Schuller | SVP, Human Resources | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 04 Oct 2024 | 10,000 | 34,035 | - | 6 | 60,000 | Common Stock |
| Shake Shack Inc (Class A) | Daniel Harris Meyer | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 110.08 per share. | 04 Oct 2024 | 10,000 | 460,337 (1%) | 0% | 110.1 | 1,100,835 | Class A Common Stock, par value $0.001 per share |
| Lifetime Brands Inc | Jeffrey Siegel | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 10,000 | 1,150,251 (5%) | 0% | 0 | Common Stock | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 339.35 per share. | 04 Oct 2024 | 9,885 | 190,137 (0%) | 0% | 339.4 | 3,354,524 | Common Stock |
| Concentrix Corp | Christopher A. Caldwell | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.70 per share. | 04 Oct 2024 | 9,823 | 241,841 | - | 52.7 | 517,708 | Common Stock |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 04 Oct 2024 | 9,552 | 1,558,071 (0%) | 0% | 1.0 | 9,648 | Common Stock |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 9,485 | 473,615 (0%) | 0% | 40.4 | 383,479 | Common Stock $.01 Par Value ND |
| PubMatic Inc Ordinary Shares | Steven Pantelick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 9,462 | 333,488 | - | - | Class B Common Stock | |
| PubMatic Inc Ordinary Shares | Steven Pantelick | CHIEF FINANCIAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 9,462 | 118,663 | - | - | Stock Option (Right to buy Class B Common Stock) | |
| Prelude Therapeutics Inc | Jane Huang | President, CMO | 04 Oct 2024 | 9,375 | 66,690 | - | - | Common Stock | ||
| Prelude Therapeutics Inc | Jane Huang | President, CMO | 04 Oct 2024 | 9,375 | 56,250 | - | - | Restricted Stock Unit | ||
| Deckers Outdoor Corp | Steven J. Fasching | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 166.67 per share. | 04 Oct 2024 | 9,198 | 161,838 (0%) | 0% | 166.7 | 1,533,031 | Common Stock |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 8,843 | 288,610 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 8,843 | 8,843 | - | - | Restricted Stock Units | |
| Upstart Holdings Inc | Paul Gu | Director, Chief Technology Offier | Sale of securities on an exchange or to another person at price $ 40.10 per share. | 04 Oct 2024 | 8,800 | 878,565 | - | 40.1 | 352,906 | Common Stock |
| Upstart Holdings Inc | Paul Gu | Director, Chief Technology Offier | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 8,800 | 25,000 | - | - | Employee Stock Option (Right to buy) | |
| Upstart Holdings Inc | Paul Gu | Director, Chief Technology Offier | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.17 per share. | 04 Oct 2024 | 8,800 | 887,365 | - | 1.2 | 10,296 | Common Stock |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 8,449 | 8,449 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 8,382 | 93,408 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 04 Oct 2024 | 8,382 | 1,588,880 (5%) | 0% | 5.0 | 41,933 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 04 Oct 2024 | 8,382 | 1,597,262 (5%) | 0% | 1.3 | 10,478 | Common Stock |
| NewtekOne Inc | Nicolas Young | President, Newtek Bank, N.A. | 04 Oct 2024 | 8,237 | 46,883 (0%) | 0% | 0 | Common stock | ||
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 8,173 | 8,173 | - | - | Warrants | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 8,082 | 89,121 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| DocGo Inc | Norman Rosenberg | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 04 Oct 2024 | 8,004 | 383,430 | - | 3.3 | 26,813 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 340.36 per share. | 04 Oct 2024 | 7,894 | 182,243 (0%) | 0% | 340.4 | 2,686,810 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 338.22 per share. | 04 Oct 2024 | 7,775 | 200,022 (0%) | 0% | 338.2 | 2,629,692 | Common Stock |
| American Battery Tech Co | Scott H. Jolcover | Chief Resource Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 7,534 | 7,534 | - | - | Warrants | |
| Enliven Therapeutics Inc | Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.51 per share. | 04 Oct 2024 | 7,522 | 1,069,887 | - | 27.5 | 206,937 | Common Stock |
| NewtekOne Inc | Halli Razon-Feingold | Director, Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 7,208 | 30,739 (0%) | 0% | 0 | Common stock | |
| CF Industries | Ashraf K. Malik | Sr. VP, Manufacturing & Distn | Sale of securities on an exchange or to another person at price $ 90.02 per share. | 04 Oct 2024 | 7,201 | 29,211 (0%) | 0% | 90.0 | 648,269 | Common stock, par value $0.01 per share |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 7,152 | 272,577 (0%) | 0% | 40.4 | 289,155 | Common Stock $.01 Par Value ND |
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 04 Oct 2024 | 7,151 | 57,242 | - | 0 | Common Stock | ||
| Certara Inc | Patrick F Smith | PRESIDENT, DRUG DEV SOLUTIONS | 04 Oct 2024 | 7,151 | 14,303 | - | - | Restricted Stock Units | ||
| Tetra Technologies Inc | Timothy C. Moeller | SVP - Supply Chain & Chemicals | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 04 Oct 2024 | 7,138 | 331,928 (0%) | 0% | 3.4 | 24,055 | Common Stock |
| MGM Resorts International | William Joseph Hornbuckle | Director, CEO AND PRESIDENT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 7,076 | 484,518 (0%) | 0% | 40.4 | 286,083 | Common Stock $.01 Par Value ND |
| Yelp Inc | Joseph R. Nachman | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 34.02 per share. | 04 Oct 2024 | 7,000 | 255,558 (0%) | 0% | 34.0 | 238,105 | Common Stock |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 6,928 | 55,208 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Clorox | Kirsten M. Marriner | EVP - Chief People Officer | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 6,898 | 38,130 (0%) | 0% | 161.6 | 1,114,510 | Common Stock |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 6,690 | 1,535,851 (0%) | 0% | 0 | Common Stock | |
| American Healthcare REIT Inc | Gabriel M. Willhite | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.07 per share. | 04 Oct 2024 | 6,643 | 149,627 | - | 25.1 | 166,540 | Common Stock |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 6,482 | 799,122 | - | - | Performance Share Units | |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 337.40 per share. | 04 Oct 2024 | 6,437 | 207,797 (0%) | 0% | 337.4 | 2,171,824 | Common Stock |
| Clorox | Angela C. Hilt | EVP - Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 6,368 | 25,061 (0%) | 0% | 161.6 | 1,028,878 | Common Stock |
| American Battery Tech Co | Andres Manuel Meza | Former Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 04 Oct 2024 | 6,367 | 186,436 (0%) | 0% | 1.0 | 6,431 | Common Stock |
| Lamb Weston | William Gerald Jurgensen | Director | 04 Oct 2024 | 6,356 | 6,356 | - | - | Stock Option (Right to Buy) | ||
| American Battery Tech Co | Scott H. Jolcover | Chief Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 6,250 | 240,133 (0%) | 0% | 0 | Common Stock | |
| American Healthcare REIT Inc | Stefan K.L. Oh | Chief Investment Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.07 per share. | 04 Oct 2024 | 6,169 | 95,459 | - | 25.1 | 154,657 | Common Stock |
| American Healthcare REIT Inc | Brian S. Peay | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.07 per share. | 04 Oct 2024 | 6,168 | 175,955 | - | 25.1 | 154,632 | Common Stock |
| ADT Inc | James D. DeVries | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 6,152 | 1,888,096 (0%) | 0% | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | William Brennan | Director, Pres & Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.57 per share. | 04 Oct 2024 | 6,149 | 509,205 | - | 32.6 | 200,273 | Ordinary Shares |
| OnKure Therapeutics Inc (Class A) | Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 5,781 | 5,781 | - | - | Employee Stock Option (right to buy) | |
| eBay | Jamie Iannone | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.09 per share. | 04 Oct 2024 | 5,625 | 559,291 (0%) | 0% | 66.1 | 371,756 | Common Stock |
| eBay | Jamie Iannone | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 66.56 per share. | 04 Oct 2024 | 5,625 | 553,666 (0%) | 0% | 66.6 | 374,400 | Common Stock |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.60 per share. | 04 Oct 2024 | 5,519 | 5,102,702 | - | 10.6 | 58,501 | Class A Common Stock |
| OnKure Therapeutics Inc (Class A) | Jason A. Leverone | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 5,322 | 5,322 | - | - | Employee Stock Option (right to buy) | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 5,272 | 91,212 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Arteris Inc | Nicholas B. Hawkins | VP and Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.13 per share. | 04 Oct 2024 | 4,958 | 211,713 | - | 7.1 | 35,351 | Common Stock |
| Palo Alto | Lee Klarich | EVP, Chief Product Officer | Sale of securities on an exchange or to another person at price $ 336.34 per share. | 04 Oct 2024 | 4,775 | 214,234 (0%) | 0% | 336.3 | 1,606,047 | Common Stock |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 4,767 | 4,767 | - | 0 | Common Stock | |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 4,765 | 4,765 | - | 0 | Common Stock | |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 4,765 | 4,765 | - | 0 | Common Stock | |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 4,765 | 4,765 | - | 0 | Common Stock | |
| Astera Labs Inc | Stefan Dyckerhoff | Director | Other type of transaction at price $ 0.00 per share. | 04 Oct 2024 | 4,765 | 4,765 | - | 0 | Common Stock | |
| FrontView REIT Inc | Ernesto Perez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,737 | 4,737 | - | - | Restricted Stock Units | |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 4,666 | 279,767 (0%) | 0% | 40.4 | 188,646 | Common Stock $.01 Par Value ND |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,556 | 4,556 | - | - | Class A Common Stock | |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,519 | 59,727 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.46 per share. | 04 Oct 2024 | 4,431 | 5,108,221 | - | 10.5 | 46,348 | Class A Common Stock |
| Clorox | Stacey Grier | EVP - Executive Chief of Staff | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 4,244 | 19,572 (0%) | 0% | 161.6 | 685,703 | Common Stock |
| MGM Resorts International | Todd R. Meinert | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,137 | 4,137 | - | - | Restricted Stock Units | |
| NewtekOne Inc | Michael Scott Price | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,119 | 27,789 (0%) | 0% | 0 | Common stock | |
| NewtekOne Inc | Frank DeMaria | EVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,119 | 32,326 (0%) | 0% | 0 | Common stock | |
| American Battery Tech Co | Scott H. Jolcover | Chief Resource Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.01 per share. | 04 Oct 2024 | 4,106 | 236,027 (0%) | 0% | 1.0 | 4,147 | Common Stock |
| DocGo Inc | Stephen Sugrue | Chief Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.35 per share. | 04 Oct 2024 | 4,104 | 185,150 | - | 3.3 | 13,748 | Common Stock |
| OnKure Therapeutics Inc (Class A) | R. Michael Carruthers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,065 | 4,939 | - | - | Class A Common Stock | |
| Fluor Corp | Joseph L. Brennan | EVP, CHIEF FINANCIAL OFFICER | 04 Oct 2024 | 4,012 | 53,527 (0%) | 0% | 50.0 | 200,622 | Common Stock | |
| American Battery Tech Co | Andres Manuel Meza | Former Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 4,008 | 170,928 (0%) | 0% | 0 | Common Stock | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,933 | 3,933 | - | - | Restricted Stock Units | |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,933 | 93,070 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| MGM Resorts International | Todd R. Meinert | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 3,927 | 3,927 | - | - | Performance Share Units | |
| Palomar Holdings Inc | Jon Christianson | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.00 per share. | 04 Oct 2024 | 3,805 | 55,731 (0%) | 0% | 15 | 57,075 | Common Stock |
| Palomar Holdings Inc | Jon Christianson | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,805 | 27,132 | - | - | Employee Stock Option (Right to Buy) | |
| Palomar Holdings Inc | Jon Christianson | President | Sale of securities on an exchange or to another person at price $ 103.04 per share. | 04 Oct 2024 | 3,805 | 51,926 (0%) | 0% | 103.0 | 392,084 | Common Stock |
| H.B. Fuller Co | Gregory O. Ogunsanya | Sr. VP, GC and Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,647 | 3,647 | - | - | Restricted Stock Units | |
| H.B. Fuller Co | Gregory O. Ogunsanya | Sr. VP, GC and Corp Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 77.18 per share. | 04 Oct 2024 | 3,647 | 3,647 (0%) | 0% | 77.2 | 281,475 | Common Stock |
| Arteris Inc | Paul L. Alpern | VP and General Counsel | Sale of securities on an exchange or to another person at price $ 7.13 per share. | 04 Oct 2024 | 3,615 | 68,084 | - | 7.1 | 25,776 | Common Stock |
| Karyopharm Therapeutics Inc | Richard Paulson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.88 per share. | 04 Oct 2024 | 3,607 | 1,135,607 (1%) | 0% | 0.9 | 3,172 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,540 | 89,868 | - | - | Employee Stock Option (right to buy) | |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 04 Oct 2024 | 3,540 | 1,588,880 (5%) | 0% | 5.0 | 17,688 | Common Stock |
| Full House Resorts Inc | Daniel R. Lee | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.25 per share. | 04 Oct 2024 | 3,540 | 1,592,420 (5%) | 0% | 1.3 | 4,425 | Common Stock |
| MGM Resorts International | Corey Ian Sanders | CHIEF OPERATING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 3,480 | 285,130 (0%) | 0% | 40.4 | 140,696 | Common Stock $.01 Par Value ND |
| Restaurant Brands Intl Inc | J. Patrick Doyle | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 3,457 | 426,198 | - | - | Restricted Share Units | |
| Verisk Analytics | Samuel G. Liss | Director | Sale of securities on an exchange or to another person at price $ 265.27 per share. | 04 Oct 2024 | 3,353 | 66,299 (0%) | 0% | 265.3 | 889,450 | Common Stock |
| Agenus Inc | Garo H. Armen | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 4.87 per share. | 04 Oct 2024 | 3,349 | 94,770 (0%) | 0% | 4.9 | 16,310 | Common Stock |
| Prelude Therapeutics Inc | Jane Huang | President, CMO | 04 Oct 2024 | 3,349 | 63,341 | - | 2 | 6,698 | Common Stock | |
| Hagerty Inc (Class A) | Robert I. Kauffman | Director | Sale of securities on an exchange or to another person at price $ 10.60 per share. | 04 Oct 2024 | 3,348 | 5,112,652 | - | 10.6 | 35,489 | Class A Common Stock |
| Ennis Inc | Vera Burnett | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.88 per share. | 04 Oct 2024 | 3,333 | 25,720 (0%) | 0% | 19.9 | 66,260 | Common Stock |
| Ennis Inc | Vera Burnett | CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,333 | 6,667 | - | - | ISO granted 4/21/2023 | |
| Ennis Inc | Boyne Wade Brewer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,333 | 6,667 | - | - | ISO granted 4/21/23 | |
| Ennis Inc | Boyne Wade Brewer | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.88 per share. | 04 Oct 2024 | 3,333 | 17,382 (0%) | 0% | 19.9 | 66,260 | Common Stock |
| Lifetime Brands Inc | Daniel Siegel | President | Gift of securities by or to the insider at price $ 0.00 per share. | 04 Oct 2024 | 3,333 | 6,733 (0%) | 0% | 0 | Common Stock | |
| Energy Vault Holdings Inc | Akshay Ladwa | Chief Engineering Officer | 04 Oct 2024 | 3,323 | 1,496,948 | - | 0.9 | 3,057 | Common Stock | |
| Clorox | Chris T. Hyder | EVP-Group Pres -Hlth & Hyg | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 3,184 | 21,806 (0%) | 0% | 161.6 | 514,439 | Common Stock |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 3,181 | 85,940 (0%) | 0% | 40.4 | 128,608 | Common Stock $.01 Par Value ND |
| Credo Tech Grp Holding Ltd | Yat Tung Lam | Director, Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.57 per share. | 04 Oct 2024 | 3,168 | 2,882,672 | - | 32.6 | 103,182 | Ordinary Shares |
| RxSight Inc | Ilya Goldshleger | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.08 per share. | 04 Oct 2024 | 3,100 | 45,346 | - | 15.1 | 46,748 | Common Stock |
| RxSight Inc | Ilya Goldshleger | See remarks | Sale of securities on an exchange or to another person at price $ 48.26 per share. | 04 Oct 2024 | 3,100 | 42,246 | - | 48.3 | 149,612 | Common Stock |
| RxSight Inc | Ilya Goldshleger | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,100 | 96,602 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Ilya Goldshleger | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Oct 2024 | 3,100 | 93,502 | - | - | Stock Option (right to buy) | |
| RxSight Inc | Ilya Goldshleger | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.08 per share. | 04 Oct 2024 | 3,100 | 45,346 | - | 15.1 | 46,748 | Common Stock |
| Applied Digital Corp | Michael Maniscalco | Chief Technology Officer | 04 Oct 2024 | 3,044 | 127,859 | - | 7.5 | 22,678 | Common Stock | |
| Generac Holdings | Rajendra Kumar Kanuru | EVP, GC, Corp. Secretary | Sale of securities on an exchange or to another person at price $ 161.19 per share. | 04 Oct 2024 | 3,000 | 13,925 (0%) | 0% | 161.2 | 483,570 | Common Stock |
| CF Industries | Bert A. Frost | EVP,Sales,MktDev,SupplyChn | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 04 Oct 2024 | 3,000 | 106,155 (0%) | 0% | 90 | 270,000 | Common stock, par value $0.01 per share |
| Darden Restaurants | Melvin John Martin | President, SRG | Sale of securities on an exchange or to another person at price $ 163.30 per share. | 04 Oct 2024 | 3,000 | 12,601 (0%) | 0% | 163.3 | 489,895 | Common Stock |
| American Battery Tech Co | Ryan Mitchell Melsert | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 2,951 | 2,951 | - | - | Warrants | |
| National Vision Holdings Inc | Patrick R. Moore | Special Advisor | 04 Oct 2024 | 2,889 | 69,770 (0%) | 0% | - | Common Stock | ||
| National Vision Holdings Inc | Patrick R. Moore | Special Advisor | 04 Oct 2024 | 2,889 | 21,069 | - | - | Restricted Stock Units | ||
| RxSight Inc | Ilya Goldshleger | See remarks | Sale of securities on an exchange or to another person at price $ 47.96 per share. | 04 Oct 2024 | 2,866 | 42,480 | - | 48.0 | 137,445 | Common Stock |
| Clorox | Angela C. Hilt | EVP - Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.57 per share. | 04 Oct 2024 | 2,734 | 21,869 (0%) | 0% | 161.6 | 441,732 | Common Stock |
| Enliven Therapeutics Inc | Samuel Kintz | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 27.50 per share. | 04 Oct 2024 | 2,730 | 1,033,793 | - | 27.5 | 75,075 | Common Stock |
| MGM Resorts International | Jonathan S. Halkyard | CHIEF FINANCIAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 2,727 | 55,221 (0%) | 0% | 40.4 | 110,253 | Common Stock $.01 Par Value ND |
| Bumble Inc (Class A) | Sissie L. Hsiao | Director | Sale of securities on an exchange or to another person at price $ 6.76 per share. | 04 Oct 2024 | 2,707 | 40,571 | - | 6.8 | 18,293 | Class A Common Stock |
| Enliven Therapeutics Inc | Joseph P. Lyssikatos | CHIEF SCIENTIFIC OFFICER | Sale of securities on an exchange or to another person at price $ 27.61 per share. | 04 Oct 2024 | 2,707 | 1,067,180 | - | 27.6 | 74,727 | Common Stock |
| Donaldson Co. Inc | Willard D. Oberton | Director | 04 Oct 2024 | 2,700 | 30,683 (0%) | 0% | 28.4 | 76,761 | Common Stock | |
| Donaldson Co. Inc | Willard D. Oberton | Director | 04 Oct 2024 | 2,700 | 0 | - | - | Employee Stock Option (right to buy) | ||
| Donaldson Co. Inc | Willard D. Oberton | Director | 04 Oct 2024 | 2,700 | 27,983 (0%) | 0% | 73.4 | 198,099 | Common Stock | |
| Weave Comm Inc | Alan Taylor | Chief Financial Officer | 04 Oct 2024 | 2,638 | 421,847 | - | 13 | 34,294 | Common Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.89 per share. | 04 Oct 2024 | 2,630 | 476,880 (0%) | 0% | 170.9 | 449,437 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 170.89 per share. | 04 Oct 2024 | 2,630 | 478,067 (0%) | 0% | 170.9 | 449,436 | Class A Common Stock |
| Restaurant Brands Intl Inc | Joshua Kobza | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,571 | 316,995 | - | - | Performance Share Units | |
| American Battery Tech Co | Andres Manuel Meza | Former Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Oct 2024 | 2,554 | 2,554 | - | - | Warrants | |
| Clorox | Kirsten M. Marriner | EVP - Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.57 per share. | 04 Oct 2024 | 2,521 | 35,172 (0%) | 0% | 161.6 | 407,318 | Common Stock |
| Lamb Weston | Andre J. Hawaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 40,126 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Charles A. Blixt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 21,770 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Robert A. Niblock | Director | 04 Oct 2024 | 2,469 | 23,335 (0%) | 0% | 0 | Common Stock | ||
| Lamb Weston | Peter J. Bensen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 15,400 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Maria Renna Sharpe | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 21,478 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | William Gerald Jurgensen | Director | 04 Oct 2024 | 2,469 | 176,238 (0%) | 0% | 0 | Common Stock | ||
| Lamb Weston | Hala G. Moddelmog | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 18,822 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Robert J. Coviello | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 13,324 (0%) | 0% | 0 | Common Stock | |
| Lamb Weston | Rita Fisher | Director | 04 Oct 2024 | 2,469 | 4,925 (0%) | 0% | 0 | Common Stock | ||
| Lamb Weston | Norman Prestage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,469 | 2,469 (0%) | 0% | 0 | Common Stock | |
| Credo Tech Grp Holding Ltd | Daniel Fleming | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.57 per share. | 04 Oct 2024 | 2,460 | 675,210 | - | 32.6 | 80,122 | Ordinary Shares |
| Datadog Inc (Class A) | Kerry S. Acocella | General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 120.06 per share. | 04 Oct 2024 | 2,452 | 74,421 (0%) | 0% | 120.1 | 294,397 | Class A Common Stock |
| FrontView REIT Inc | Elizabeth F. Frank | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,369 | 2,369 | - | - | Restricted Stock Units | |
| FrontView REIT Inc | Daniel E. Swanstrom | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,369 | 2,369 | - | - | Restricted Stock Units | |
| FrontView REIT Inc | Noelle Leveaux | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,369 | 2,369 | - | - | Restricted Stock Units | |
| OnKure Therapeutics Inc (Class A) | Nicholas A. Saccomano | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,359 | 2,359 | - | - | Employee Stock Option (right to buy) | |
| ADT Inc | Thorsen Wayne | EVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,333 | 412,169 (0%) | 0% | 0 | Common Stock | |
| Torrid Holdings Inc | Bridgett C. Zeterberg | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.55 per share. | 04 Oct 2024 | 2,316 | 157,308 | - | 3.6 | 8,222 | Common Stock |
| MGM Resorts International | Todd R. Meinert | SVP & Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,309 | 24,228 (0%) | 0% | 0 | Common Stock $.01 Par Value ND | |
| Clorox | Linda J. Rendle | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.57 per share. | 04 Oct 2024 | 2,208 | 133,302 (0%) | 0% | 161.6 | 356,747 | Common Stock |
| MGM Resorts International | John M. McManus | CHIEF LEGAL ADMIN OFC AND SECY | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.43 per share. | 04 Oct 2024 | 2,075 | 89,137 (0%) | 0% | 40.4 | 83,892 | Common Stock $.01 Par Value ND |
| BlackRock MuniYield Pennsylvania Quality Fund | Phillip Soccio | Portfolio Manager | Sale of securities on an exchange or to another person at price $ 12.44 per share. | 04 Oct 2024 | 2,056 | 0 (0%) | 0% | 12.4 | 25,579 | Common Stock |
| Clorox | Stacey Grier | EVP - Executive Chief of Staff | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 2,016 | 21,588 (0%) | 0% | 161.6 | 325,725 | Common Stock |
| Clorox | Chris T. Hyder | EVP-Group Pres -Hlth & Hyg | Grant, award, or other acquisition of securities at price $ 161.57 per share. | 04 Oct 2024 | 2,016 | 23,822 (0%) | 0% | 161.6 | 325,725 | Common Stock |
| American Battery Tech Co | Scott H. Jolcover | Chief Resource Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2024 | 2,012 | 233,883 (0%) | 0% | 0 | Common Stock | |
| CF Industries | Susan L. Menzel | EVP and Chief Admin. Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 04 Oct 2024 | 2,000 | 66,268 (0%) | 0% | 90 | 180,000 | Common stock, par value $0.01 per share |
| Paylocity Holding Corp | Joshua Scutt | Senior Vice President Sales | Sale of securities on an exchange or to another person at price $ 170.00 per share. | 04 Oct 2024 | 1,975 | 41,716 (0%) | 0% | 170 | 335,750 | Common Stock, par value $0.001 |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.